Molecule Information
General Information of the Molecule (ID: Mol04319)
| Name |
Guanine nucleotide-binding protein G(i) subunit alpha-2 (GNAI2)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Adenylate cyclase-inhibiting G alpha protein
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
GNAI2
|
||||
| Gene ID | |||||
| Sequence |
MGCTVSAEDKAAAERSKMIDKNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEDG
YSEEECRQYRAVVYSNTIQSIMAIVKAMGNLQIDFADPSRADDARQLFALSCTAEEQGV L PDDLSGVIRRLWADHGVQACFGRSREYQLNDSAAYYLNDLERIAQSDYIPTQQDVLRT RV KTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSAYDLVLAE DEE MNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKITHSPLTICFPEYTGANK YDEA ASYIQSKFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF Click to Show/Hide
|
||||
| Function |
Guanine nucleotide-binding proteins are involvedas modulators or transducers in various transmembrane signalingsystems. The G proteins are involved in hormonal regulation ofadenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. May play a role in cell division.{ECO:0000269|PubMed:17635935}.; [Isoform sGi2]: Regulates the cell surface density ofdopamine receptors DRD2 by sequestrating them as an intracellular pool.{ECO:0000269|PubMed:17550964}.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Prostate cancer [ICD-11: 2C82.0] | [1] | |||
| Resistant Disease | Prostate cancer [ICD-11: 2C82.0] | |||
| Resistant Drug | Cabazitaxel | |||
| Molecule Alteration | Phosphorylation | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Oxytocin signaling pathway | Activation | hsa04921 | |
| In Vitro Model | DU145CR cells | prostate | Homo sapiens (Human) | N.A. |
| Experiment for Molecule Alteration |
MS analysis | |||
| Mechanism Description | Pathway analysis revealed that clusters in two cases showed up-regulation of the oxytocin (OXT) receptor-signaling pathway. Spatial gene expression analysis of CBZ-resistant prostate cancer tissues confirmed the heterogeneous expression of OXT-signaling molecules. We identified the OXT-signaling pathway as a potential target for CBZ-resistant CRPC using single-cell transcriptomic analysis of CTCs. CLO may potentially overcome CBZ resistance in CRPC by inhibiting the OXT-signaling pathway. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
